MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
  • F1 crossbreds of C57BL/6 and CD-1 mice demonstrate resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced nigral neurodegeneration

    P.A. Alladi, D. Vidyadhara, H. Yarreiphang, T.R. Raju (Bengaluru, India)

  • Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease

    A. Gündüz, S. Yagci, S. Aydin, B.Ç. Poyraz, G. Genç, S. Oguz, H. Apaydin, G. Kiziltan, H. Hanagasi, M. Hanci, S. Ertan (Istanbul, Turkey)

  • Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

    D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

  • Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies

    M. Takahashi, T. Uchihara, M. Yoshida, K. Wakabayashi, A. Kakita, H. Takahashi, S. Toru, T. Kobayashi, S. Orimo (Tokyo, Japan)

  • Factors associated with falling in early, treated Parkinson’s disease: The NET-PD LS1 cohort

    K.L. Chou, J.J. Elm, C.L. Wielinski, D.K. Simon, M.J. Aminoff, C.W. Chadwick, G.S. Liang, R.A. Hauser, L. Sudarsky, C.C. Umeh, T. Voss, J. Juncos, J.Y. Fang, J.T. Boyd, I. Bodis-Wollner, M. Zoltan, J.C. Morgan, A.M. Wills, S.L. Lee, S.A. Parashos, On behalf of the NINDS NET-PD Investigators (Ann Arbor, MI, USA)

  • Factors related to psychotic symptoms in patients with Parkinson’s disease

    B. Tserensodnom (Ulaanbaatar, Mongolia)

  • Fahr’s syndrome in a Filipino female with hearing loss and polycystic ovaries: A case report

    P.D. Dadgardoust, R.L. Rosales (Manila, Philippines)

  • Faithful SGCE imprinting in iPSC-derived cortical neurons: An endogenous model system of myoclonus-dystonia

    K. Grütz, P. Seibler, A. Weißbach, K. Lohmann, F.A. Carlisle, D.J. Blake, A. Westenberger, C. Klein, A. Grünewald (Lübeck, Germany)

  • Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study

    S. Heinzel, M. Maechtel, S.E. Hasmann, M.A. Hobert, T. Heger, D. Berg, W. Maetzler (Tübingen, Germany)

  • Fall status and stepping response: Individuals with PD are differently influenced by side-affected

    B.N. Intzandt, E. Beck, M.P. Pereira, Q.J. Almeida (Waterloo, ON, Canada)

  • Falls and frailty predicate escalating care needs in Parkinson’s disease

    B. Mohamed, C. Thomas, H. Shukla, S. Aithal (Cardiff, United Kingdom)

  • Falls in Parkinson’s disease : Effects on health related quality of life

    T.H. Farombi, J. Yaria, M.O. Owolabi, A. Ogunniyi (Ibadan, Nigeria)

  • Falls in Parkinson’s disease: Beware the short, slow steps

    A. Lieberman, A. Deep, S. Shafer, T. Lockhart (Phoenix, AZ, USA)

  • Familial cortical myoclonic tremor with epilepsy in Chinese population: Clinical and neurophysiologic features in nine pedigrees from People’s Republic of China

    Z. Cen, C. Huang, H. Yin, F. Xie, X. Lu, Z. Ouyang, Y. Lou, X. Qiu, Z. Wang, J. Xiao, M. Ding, W. Luo (Hangzhou, People's Republic of China)

  • Familial Parkinson’s disease in Ireland

    D.A. Olszewska, A. McCarthy, B. Magennis, O. Ross, T. Lynch (Dublin, Ireland)

  • Familial Parkinson’s disease in the Province of Quebec

    L.L. Farrell, E. Pourcher, E. Nosova, M. McKenzie, I. Guella, D.M. Evans, C. Déry, M.J. Farrer (Vancouver, BC, Canada)

  • Familial SPG17/distal hereditary motor neuropathy type V– Complicated hereditary spastic paraplegia with many faces

    T. Musacchio, A.K. Zaum, N. Üceyler, C. Sommer, N. Pfeifroth, K. Reiners, E. Kunstmann, J. Volkmann, S. Rost, S. Klebe (Würzburg, Germany)

  • Fast and simple non-invasive screening tool for mitochondrial changes in Huntington’s disease

    P. Dušek, M. Rodinová, I. Lišková, E. Trefilová, Z. Ellederová, J. Klempír, J. Roth, H. Hansíková (Prague, Czech Republic)

  • FBOX07 mutation with juvenile parkinsonism and behavioral disorders

    M. Kuzu, F.N. Durmaz, Ç. Ulukan, H. Kaymakçalan, A.O. Çaglayan, C. Akbostanci (Ankara, Turkey)

  • Feasibility and effectiveness of a low-threshold psychoeducative group-intervention for depression in Parkinson’s disease

    K. Linse, M. Fauser, C. Ossig, A. Hermann, A. Storch (Dresden, Germany)

  • Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease

    K.J. Seidler, R.P. Duncan, M.E. McNeely, M.E. Hackney, G.M. Earhart (St. Louis, MO, USA)

  • Feasibility and preliminary outcomes of an interdisciplinary home visit program for patients with advanced Parkinson’s disease

    J.E. Fleisher, M.M. Sweeney, S. Oyler, A.C. Lemen, A. Fazl, G. Dacpano, R.M. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)

  • Feasibility of implementing a long-term mobile device program in PD patients

    L.R. Bataille, L.D. Herron, M. Afek, I. Feldman, C. Admati, S. Chowdhury (New York, NY, USA)

  • Feasibility, safety and effects of a group intervention based on European physiotherapy guideline for Parkinson´s disease

    J.E. Pompeu, T.B. Freitas, R.A. Nuvolini, K.G. Silva, F. Doná, R.A. Andreotti, N.A. Mazzini, M.G.R. Almeida, C. Torriani-Pasin (Sao Paulo, Brazil)

  • Features of the quality of life and related disorders in patients with focal dystonia

    Z.A. Akbarkhodjaeva, G.S. Rakhimbaeva (Tashkent, Uzbekistan)

  • Fiberoptic endoscopic evaluation of swallowing findings in patients with Machado-Joseph disease

    J.L. Pedroso, G.L.A. Diaféria, S.W. Park, L. Haddad, F.L.M. Haddad, O.P. Barsottini (São Paulo, Brazil)

  • Fifteen years of clinical trials in Huntington’s disease: Too many clinical trial failures

    A.M. Travessa, F.B. Rodrigues, T.A. Mestre, C. Sampaio, J.J. Ferreira (Lisboa, Portugal)

  • Fighting Freezing of gait in Parkinson’s disease: Effect of a phase-dependent tactile biofeedback

    M. Mancini, K. Smulders, G. Harker, A.C. Fortaleza, J.G. Nutt, F.B. Horak (Portland, OR, USA)

  • Finding an optimal lead trajectory for a better stimulated volume in movement disorder therapy

    J. Perez, L. Cif, V. Gonzalez, E. Sanrey, F. Cyprien, P. Coubes (Montpellier, France)

  • Finger tapping distance in idiopathic normal pressure hydrocephalus changes in parallel with frontal lobe function

    N. Nishida, Y. Sano, A. Kandori, H. Toda, S. Matsumoto, K. Iwasaki, M. Ishikawa (Osaka, Japan)

  • Finger tapping-related brain activation and impact of cerebellar theta-burst stimulation in cervical dystonia patients

    T.M. Odorfer, G.A. Homola, J. Volkmann, D. Zeller (Wuerzbuerg, Germany)

  • First documented case of burning mouth syndrome (BMS) responsive to levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson’s disease (PD)

    X.X. Yu, H. Fernandez (Cleveland, OH, USA)

  • Floor square size predicts step count of 360° turns in PD patients with freezing

    U.M. Fietzek, L. Stuhlinger, A. Plate, A.O. Ceballos-Baumann, K. Bötzel (Munich, Germany)

  • Focusing precision and lesion size in cerebello-thalamo-tractotomy by MR imaging-guided high intensity focused ultrasound (MRgFUS)

    R.G. Bauer, E. Martin, S. Hägele-Link, K. Georg, W.A. Nikolas, L. Anita, J. Alfred, B. Amanda, S.R. Sebastian, W. Beat (St. Gallen, Switzerland)

  • Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research

    I. Feldman, M. Afek, L. Bataille (Gedera, Israel)

  • Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

    C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

  • Fragile X-associated tremor/ataxia syndrome in two female patients

    L. Hvizdosova, M. Kaiserova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

  • Freezing of gait (FOG) in PD: Is electroencephalography (EEG) a gateway to elucidating the pathophysiology?

    T. Munteanu, E.J. Baird, C. Fearon, S.M. Waechter, C. McDonnell, J. Gallego, B. Quinlivan, I. Killane, J.S. Butler, T. Lynch, R.B. Reilly (Dublin, Ireland)

  • Freezing of gait in extrapontine myelinolysis

    Y.N. Kwon, D. Lee, T.B. Ahn (Jindo-gun, Korea)

  • Freezing of gait in Parkinson’s disease: A stopping deficit?

    K. Smulders, D.S. Peterson, M. Mancini, J.G. Nutt, F.B. Horak, B.W. Fling (Portland, OR, USA)

  • Freezing of gait is associated with more fear of falling avoidance behavior and less participation in daily physical activity

    M.R. Landers, B. Poston, J. Nash, J. Longhurst (Las Vegas, NV, USA)

  • Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease

    K.A. Schindlbeck, W. Naumann, D.J. Friedrich, S. Schönfeld, A. Maier, F. Klostermann, F. Marzinzik (Berlin, Germany)

  • Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

  • Frequency and types of dystonia in Wilson’s disease patients

    K. Dziezyc, T. Litwin, G. Chabik, A. Czlonkowska (Warsaw, Poland)

  • Frequency of GBA1 and LRRK2 G2019S mutations, and body mass index in Ashkenazi Jews

    N. Doan, D. Raymond, R.A. Ortega, J. Ratliff, I. Meijer, J. Squires, S. Buckingham, B. Johannes, A. Vaigast, I. Perera, W.C. Nichols, L. Ozelius, J. Miravite, L. Severt, V. Shanker, N. Lubarr, S. Bressman, R. Saunders-Pullman (New York, NY, USA)

  • Frequency of echogenic abnormality of the substantia nigra is increased in methamphetamine users

    J.J. Rumpf, J. Albers, C. Fricke, D. Weise, J. Classen (Leipzig, Germany)

  • Frequency of falls in nursing homes for neurodegenerative diseases

    C. Godinho, J.M. Domingos, A.S. Pereira, M. Duarte, J.J. Ferreira (Lisboa, Portugal)

  • Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease

    M. Salari, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

  • Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease

    M. Muthuraman, G. Deuschl, C. Riedel, J. Volkmann, S. Groppa (Mainz, Germany)

  • Frontal dysfunction in Tourette syndrome: A PET-FDG study

    R. García-Ramos, N. Gonzalez, E. Lopez Valdes, F. Alonso, N. Cabrera, I. Parees, M.J. Catalán, J. Matías-Guíu Antem (Madrid, Spain)

  • Frontal lobe white matter atrophy correlates with disability in spastic paraplegia type 11 (SPG11)

    I. Faber, A.R.M. Martinez, T.T.J. Rezende, R.F. Casseb, C.M. Lourenço, W. Marques Jr, J.L. Pedroso, O.G.P. Barsottini, I.T. Lopes-Cendes, M.C. França Jr (Campinas, Brazil)

  • Functional characterisation and the selective vulnerability of SNCA (A30P) patient-derived midbrain dopaminergic neurons to ER stress

    P.A. Barbuti, B.F.R. Santos, S. Delcambre, Y. Nonnenmacher, C.D. Obermaier, A. Hummel, K. Hiller, R. Krueger (Belvaux, Luxembourg)

  • Functional characterization of the upstream start codon in the GCH1 gene

    L.C. Jones, E. Davila, L.K. Goode, P.G. Bhide, I. Armata (Tallahassee, FL, USA)

  • Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders

    A. Campabadal, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, C. Uribe, A.I. Garcia-Diaz, A. Abos, C. Junque (Barcelona, Spain)

  • Functional connectivity during resting state in Parkinson’s disease patients with and without mild cognitive impairment

    O. Monchi, A. Nagano-Saito, A. Hanganu, S. Jobert, B. Mejia-Constain, C. Degroot, A.L. Lafontaine, H. Chertkow, A. Tam, P. Orban, P. Bellec, O. Monchi (Calgary, AB, Canada)

  • Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson’s disease

    A. Giordano, R. De Micco, G. Caiazzo, A. Russo, M. Cirillo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)

  • Functional connectome organization is altered in PD patients with mild cognitive impairment

    S. Galantucci, F. Agosta, I. Stankovic, S. Basaia, T. Stojkovic, E. Stefanova, E. Canu, A. Meani, V.S. Kostic, M. Filippi (Milan, Italy)

  • Functional deficits during response inhibition improve after dopaminergic medication for Parkinson

    C. Vriend, J.P. Trujillo, N.J.H.M. Gerrits, H.W. Berendse, Y.D. van der Werf, O.A. van den Heuvel (Amsterdam, Netherlands)

  • Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington´s disease – A case report

    T.T.C. Capato, R.G. Cury, R. Gimaães, E.T. Fonoff, M.S. Haddad (São Paulo, Brazil)

  • Fundamental differences in Parkinsonian rat limbic regions contribute to anxious behavior and diminished responsiveness to diazepam

    K.A. O'Connor, P.J. Feustel, A. Ramirez-Zamora, E. Molho, J.G. Pilitsis, D.S. Shin (Albany, NY, USA)

  • FYN expression is associated with regulatory region genetic variation

    L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley